Head-To-Head Comparison: Civitas Solutions (CIVI) & Emeritus (ESC)

Civitas Solutions (NYSE: CIVI) and Emeritus (NYSE:ESC) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Insider and Institutional Ownership

94.2% of Civitas Solutions shares are held by institutional investors. 5.3% of Civitas Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.


This table compares Civitas Solutions and Emeritus’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Civitas Solutions 0.43% 16.25% 2.49%
Emeritus N/A N/A N/A

Analyst Ratings

This is a breakdown of current ratings and price targets for Civitas Solutions and Emeritus, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Civitas Solutions 0 0 2 0 3.00
Emeritus 0 0 0 0 N/A

Civitas Solutions currently has a consensus price target of $25.50, suggesting a potential upside of 42.46%.

Earnings and Valuation

This table compares Civitas Solutions and Emeritus’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Civitas Solutions $1.47 billion 0.45 $6.33 million $0.17 105.29
Emeritus N/A N/A N/A ($3.16) N/A

Civitas Solutions has higher revenue and earnings than Emeritus. Emeritus is trading at a lower price-to-earnings ratio than Civitas Solutions, indicating that it is currently the more affordable of the two stocks.


Civitas Solutions beats Emeritus on 8 of the 8 factors compared between the two stocks.

About Civitas Solutions

Civitas Solutions, Inc. is a provider of home- and community-based health and human services to individuals with intellectual, developmental, physical or behavioral disabilities and other special needs. The Company operates through two segments: Human Services and Post-Acute Specialty Rehabilitation Services (SRS). The Human Services segment provides home- and community-based human services to individuals with intellectual and/or developmental disabilities (I/DD), youth with emotional, behavioral and/or medically complex challenges or at-risk youth (ARY), and elders. The SRS segment delivers healthcare and community-based health and human services to individuals having suffered acquired brain injury, spinal injuries, and other catastrophic injuries and illnesses. Within its SRS segment, its NeuroRestorative business unit is focused on rehabilitation and transitional living services, and its CareMeridian business unit is focused on the medically-intensive post-acute care services.

About Emeritus

Emeritus Corporation (Emeritus) is engaged in operations of senior living communities in the United States. The Company owns and operates a portfolio of communities providing services to its residents, including independent living, assisted living, specialized memory care, and, to a lesser extent, skilled nursing care. The Company provides a variety of supportive living services in a professionally staffed environment that enables seniors to live with dignity and independence. During the year ending December 31, 2012, the Company added home healthcare to its service offerings, through its acquisition of Florida-based Nurse on Call, Inc. (NOC). As of December 31, 2012, the Company operated 483 senior living communities in 45 states. The communities consisted of approximately 43,000 residential rooms or suites (collectively units) with a resident capacity for approximately 50,100 residents.

Receive News & Ratings for Civitas Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Civitas Solutions and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit